Search

everythinglearnresearchcommunity

for

Search:↓

Understanding and manipulating epigenetic changes can potentially lead to human organ regeneration therapies, but more research is needed to improve these methods and minimize risks.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

A patient's grey hair regained color during treatment with adalimumab.

Cyclosporine can reverse hair graying.

Alopecia areata may involve stress-related changes affecting hormone receptors, leading to reduced cortisol production.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

ILC1-like cells can independently cause alopecia areata.

RXRα is crucial for proper immune response and links diet to immune function.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Engineered cytokines show promise for improving tissue healing and safety in regenerative medicine.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

A kidney transplant and immunosuppressive treatment stopped the skin disease in a patient.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

CD4 is crucial for maintaining skin stem cell balance and aiding wound healing.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Immune therapy for cancer can cause hair loss scars in some patients.

Women and men experience different quality of life and symptom distress after kidney transplant with immunosuppressive therapy.

Human skin models are essential for studying skin's sensory, immune, and nervous system interactions.

Hair follicles could help develop eye treatments by studying immune responses.

Hsa-miR-193a-5p is important in alopecia areata by promoting inflammation and involving specific genes in hair and immune function.